Results 21 to 30 of about 897 (146)

A COMPARISON OF EFFICACY AND SAFETY OF CLOZAPINE AND SULPIRIDE IN TREATMENT-RESISTANT SCHIZOPHRENIA

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Object: In this study, a comparison of efficacy and tolerability of clozapine and sulpiride on treatment-resistant-schizophrenia was aimed. Method: Thirty-six in-patients with treatment-resistant schizophrenia, diagnosed according to DSM-IV diagnostic
Hasan Herken   +4 more
doaj  

Arrhythmic markers and clozapine in patients with schizophrenia: effect of 10 weeks clozapine treatment on heart rate variability, late potentials and QT dispersion

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Clozapine is a well-known atypical antipsychotic agent which is especially useful in patients with treatment-resistant schizophrenia, but there is still debate on its potential to cause arrhythmia and sudden death.
Mevhibe N. Tümüklü   +8 more
doaj  

Combination treatments in schizophrenia

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Use of multiple antipsychotic agents in patients with schizophrenia, especially in treatment resistant schizophrenia, is common practice in psychiatry, although most schizophrenia guidelines recommend monotherapy.
Vesile Altınyazar, Nevzat Yüksel
doaj   +1 more source

TINJAUAN PENGGUNAAN ANTIPSIKOTIK PADA PENGOBATAN SKIZOFRENIA DI RUMAH SAKIT PROF. DR. V. L. RATUMBUYSANG MANADO PERIODE JANUARI 2013-MARET 2013 [PDF]

open access: yes, 2013
Schizophrenia is one of psychiatric disorders that caused by brain damage. The prevalence ofSchizophrenia patients in North Sulawesi were 2,4%. One way of Schizophrenia handling isgiving antipsychotics to prevent the symptoms. The aim of this research is
Fatimawali, Fatimawali   +2 more
core   +2 more sources

Pimozide augmentation of clozapin: A case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Although clozapine is the gold standard in treatment of resistant schizophrenia, it is ineffective at more than 50% of patients and needs augmentation therapies.
Mine Ergelen   +2 more
doaj  

Augmentation of clozapine with aripiprazole in treatment-resistent schizophrenia: A case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Clozapine is the treatment of choice for non-responder schizophrenic patients, with beneficial effects in terms of mental state and suicide mortality.
Osman Yıldırım   +4 more
doaj  

Treatment of Pediatric Bipolar Disorder [PDF]

open access: yes, 2014
Although once pediatric bipolar disorder had been perceived as a very rarely seen psychiatric disorder, studies conducted within the last two decades revealed that this disorder is more often than assumed.
Ayten Erdogan, Ozhan Yalcin, Sema Kurban
core   +1 more source

CLOZAPINE USE IN CASE WITH TREATMENT RESİSTANT CATATONIC SCHIZOPHRENIA AND TARDIVE DYSKINESIA

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Clozapine use in a case with treatment resistant catatonic schizophrenia and tardive dyskinesia is an alternative treatment with superior efficacy in a substantial proportion of typical antipsychotic treatment-resistant schizophrenic patients.
Turgut Kundakçı
doaj  

A case report of chronic schizophrenia: From combined treatment to monotherapy and decrease in positive symptoms with decreasing dose of clozapine

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Clozapine is one of the most effective drugs in treatment resistant schizophrenia, schizoaffective and bipolar disorder. There is limited evidence to support the combination of multiple antipsychotics in treatment resistant schizophrenia, in the ...
Hayriye Dilek Yalvaç   +4 more
doaj  

Very early onset schizophrenia and clozapine: case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Schizophrenia is known as a very rare illness prior to teen ages and when it is seen before 13 age, is defined as very early onset schizophrenia. In this article we reported a girl-child who was eleven years old and her symptoms had begun when she was 6
Aynur Pekcanlar Akay   +2 more
doaj  

Home - About - Disclaimer - Privacy